Narcolepsy Type 1 Clinical Trial
Official title:
Effectiveness of Group Psychotherapy in Patients With Narcolepsy Type 1
Verified date | February 2023 |
Source | Cantonal Hospital of St. Gallen |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The aim of this pilot study is to test the benefit of behavior therapy-oriented, method-integrated psychotherapy in an outpatient group setting in patients with narcolepsy type 1. Therefore we collect and evaluate initial data on its effectiveness on the disease in terms of specific symptomatology, emotion regulation, health-related quality of life, and disease processing/acceptance.
Status | Completed |
Enrollment | 10 |
Est. completion date | December 31, 2022 |
Est. primary completion date | March 31, 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Diagnosed narcolepsy type 1 according to AASM, examined by an experienced sleep physician including history, clinical examination, polysomnographic examination (PSG) with a multiple sleep latency test (MSLT), possibly also including determination of HLA DQB1 * 062 and orexin A / hypocretin 1 - Age between 18 and 65 years - Signed informed consent - Exclusion of other clinically relevant organic sleep disorders by means of polysomnography (AHI>10/h) Exclusion Criteria: - Presence of severe psychiatric comorbidity - Other psychotherapy during the study period - Change of medication used for narcolepsy therapy shortly before the start and during the study period including follow-up measurement. In this case, patients may still complete group therapy, but the data will not be included in the analysis. |
Country | Name | City | State |
---|---|---|---|
Switzerland | Clinic for Psychosomatic Medicine, Cantonal Hospital St.Gallen | St.Gallen |
Lead Sponsor | Collaborator |
---|---|
Cantonal Hospital of St. Gallen |
Switzerland,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Fatigue (Severity) | German version of the questionnaire "Fatigue Severity Scale" (FSS; Valko et al., 2008) | Week 0-24 | |
Primary | Daytime sleepiness | German version of the questionnaire "Epworth Sleepiness Scale" (ESS; Johns, 1991) | Week 0, Week 6, Week 12, Week 24 | |
Primary | Sleep quality | German version of the questionnaire "Pittsburgh Sleep Quality Index" (PSQI; Buysse et al., 2008) | Week 0-24 | |
Primary | Emotion regulation | German questionnaire "Fragebogen zur Erhebung der Emotionsregulation bei Erwachsenen" (FEEL-E; Grob et al., 2014) | Week 0-24 | |
Secondary | Disease processing, acceptance & coping | German questionnaire "Freiburger Fragebogen zur Krankheitsverarbeitung" (FKV-LIS-SE; Muthny, 1989) | Week 0, Week 6, Week 12, Week 24 | |
Secondary | Anxiety & depression | German version of the questionnaire "Hospital Anxiety and Depression Scale" (HADS; Herrmann et al., 1995; Herrmann-Lingen et al., 2011; Zigmond & Snaith, 1983) | Week 0, Week 6, Week 12, Week 24 | |
Secondary | Health-related quality of life (HRQOL) | German version of the questionnaire "Short Form 12 Health Survey" (SF-12; Morfeld et al., 2012) | Week 0-24 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT05983731 -
A Pilot Observational Study to Assess the Ability of Continuous 'Home' EEG to Accurately Diagnose Narcolepsy and Demonstrate Response to Treatment
|
||
Suspended |
NCT04419792 -
'A Profile of Physical Performance Variables in an Out-patient Adult Population With Narcolepsy'
|
||
Completed |
NCT05375890 -
Clinical and Neurophysiological Characteristics of Narcolepsy
|
||
Not yet recruiting |
NCT06292598 -
Bacterial Translocation and Gut Microbiota in Type 1 Narcolepsy Patients Versus a Control Population
|
||
Recruiting |
NCT06358950 -
A Study to Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Narcolepsy Type 1 (ALKS 2680-201)
|
Phase 2 | |
Not yet recruiting |
NCT06457945 -
Mind-wandering and Predictive Processes in Narcolepsy: a Putative Mechanism Through Covert REM Intrusions
|
N/A | |
Not yet recruiting |
NCT06383806 -
Decreasing Nightmares in Adults With Narcolepsy
|
N/A | |
Not yet recruiting |
NCT05914194 -
A Eight-Week Study of NLS-2 (Mazindol Extended Release) in Participants With Narcolepsy Type 1
|
Phase 3 | |
Completed |
NCT05687903 -
A Study of TAK-861 in Participants With Narcolepsy Type 1
|
Phase 2 | |
Recruiting |
NCT05967832 -
Contribution of 7 Tesla MRI of the Hypothalamus in the Diagnosis of Type 1 Narcolepsy
|
N/A | |
Completed |
NCT05709873 -
Narcolepsy Nightmare Study
|
N/A | |
Recruiting |
NCT04483310 -
Meditation-Relaxation (MR Therapy) for Sleep Paralysis.
|
N/A | |
Completed |
NCT04445129 -
Wake and Sleep State Transitions on a Portable Electroencephalogram (EEG) Device in Narcolepsy Type 1 (NT1) and Healthy Participants
|
||
Completed |
NCT05460052 -
Evaluation of the Effectiveness of a Physical Activity Program on the Severity of Narcolepsy
|
||
Recruiting |
NCT05816382 -
A Study of TAK-861 for the Treatment of Selected Central Hypersomnia Conditions
|
Phase 2/Phase 3 | |
Recruiting |
NCT06336057 -
Mentalizating in Adults Suffering From Narcolepsy Type 1.
|
||
Recruiting |
NCT06251063 -
Improving Social Relationships for Adolescents With Central Disorders of Hypersomnolence
|
N/A | |
Completed |
NCT06241911 -
Transcutaneous Auricular Vagus Nerve Stimulation in Patients With Narcolepsy Type 1
|
N/A |